• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧诱导因子是心血管疾病发病机制和病理生理学的核心因素。

Hypoxia Inducible Factors as Central Players in the Pathogenesis and Pathophysiology of Cardiovascular Diseases.

作者信息

Lucero García Rojas Emilio Y, Villanueva Cleva, Bond Richard A

机构信息

Department of Pharmacology and Pharmaceutical Sciences, University of Houston, Houston, TX, United States.

Instituto Politecnico Nacional, Escuela Superior de Medicina, Mexico City, Mexico.

出版信息

Front Cardiovasc Med. 2021 Aug 10;8:709509. doi: 10.3389/fcvm.2021.709509. eCollection 2021.

DOI:10.3389/fcvm.2021.709509
PMID:34447792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8382733/
Abstract

Cardiovascular (CV) diseases are the major cause of death in industrialized countries. The main function of the CV system is to deliver nutrients and oxygen to all tissues. During most CV pathologies, oxygen and nutrient delivery is decreased or completely halted. Several mechanisms, including increased oxygen transport and delivery, as well as increased blood flow are triggered to compensate for the hypoxic state. If the compensatory mechanisms fail to sufficiently correct the hypoxia, irreversible damage can occur. Thus, hypoxia plays a central role in the pathogenesis and pathophysiology of CV diseases. Hypoxia inducible factors (HIFs) orchestrate the gene transcription for hundreds of proteins involved in erythropoiesis, glucose transport, angiogenesis, glycolytic metabolism, reactive oxygen species (ROS) handling, cell proliferation and survival, among others. The overall regulation of the expression of HIF-dependent genes depends on the severity, duration, and location of hypoxia. In the present review, common CV diseases were selected to illustrate that HIFs, and proteins derived directly or indirectly from their stabilization and activation, are related to the development and perpetuation of hypoxia in these pathologies. We further classify CV diseases into acute and chronic hypoxic states to better understand the temporal relevance of HIFs in the pathogenesis, disease progression and clinical outcomes of these diseases. We conclude that HIFs and their derived factors are fundamental in the genesis and progression of CV diseases. Understanding these mechanisms will lead to more effective treatment strategies leading to reduced morbidity and mortality.

摘要

心血管(CV)疾病是工业化国家的主要死因。CV系统的主要功能是向所有组织输送营养物质和氧气。在大多数CV病理过程中,氧气和营养物质的输送会减少或完全停止。机体触发了多种机制,包括增加氧气运输和输送以及增加血流量,以补偿缺氧状态。如果代偿机制未能充分纠正缺氧,就可能发生不可逆的损伤。因此,缺氧在CV疾病的发病机制和病理生理学中起着核心作用。缺氧诱导因子(HIFs)协调数百种参与红细胞生成、葡萄糖转运、血管生成、糖酵解代谢、活性氧(ROS)处理、细胞增殖和存活等过程的蛋白质的基因转录。HIF依赖基因表达的整体调控取决于缺氧的严重程度、持续时间和位置。在本综述中,选择了常见的CV疾病来说明HIFs以及直接或间接源于其稳定和激活的蛋白质与这些病理过程中缺氧的发生和持续存在有关。我们进一步将CV疾病分为急性和慢性缺氧状态,以更好地理解HIFs在这些疾病的发病机制、疾病进展和临床结果中的时间相关性。我们得出结论,HIFs及其衍生因子在CV疾病的发生和发展中至关重要。了解这些机制将带来更有效的治疗策略,从而降低发病率和死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab6/8382733/999ae8d2aa70/fcvm-08-709509-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab6/8382733/3e84d67f8aea/fcvm-08-709509-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab6/8382733/912375b0edfe/fcvm-08-709509-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab6/8382733/999ae8d2aa70/fcvm-08-709509-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab6/8382733/3e84d67f8aea/fcvm-08-709509-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab6/8382733/912375b0edfe/fcvm-08-709509-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab6/8382733/999ae8d2aa70/fcvm-08-709509-g0003.jpg

相似文献

1
Hypoxia Inducible Factors as Central Players in the Pathogenesis and Pathophysiology of Cardiovascular Diseases.缺氧诱导因子是心血管疾病发病机制和病理生理学的核心因素。
Front Cardiovasc Med. 2021 Aug 10;8:709509. doi: 10.3389/fcvm.2021.709509. eCollection 2021.
2
The role of hypoxia-inducible factors in cardiovascular diseases.缺氧诱导因子在心血管疾病中的作用。
Pharmacol Ther. 2022 Oct;238:108186. doi: 10.1016/j.pharmthera.2022.108186. Epub 2022 Apr 9.
3
Emerging roles of hypoxia-inducible factors and reactive oxygen species in cancer and pluripotent stem cells.缺氧诱导因子和活性氧在癌症及多能干细胞中的新作用
Kaohsiung J Med Sci. 2015 Jun;31(6):279-86. doi: 10.1016/j.kjms.2015.03.002. Epub 2015 Apr 25.
4
Specific Inhibition of HIF Activity: Can Peptides Lead the Way?对缺氧诱导因子(HIF)活性的特异性抑制:肽类能引领方向吗?
Cancers (Basel). 2021 Jan 22;13(3):410. doi: 10.3390/cancers13030410.
5
Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism.缺氧诱导因子与脂代谢的调控。
Cells. 2019 Mar 3;8(3):214. doi: 10.3390/cells8030214.
6
Hypoxia-inducible factors and hypoxic cell death in tumour physiology.肿瘤生理学中的缺氧诱导因子与缺氧性细胞死亡
Ann Med. 2004;36(7):530-9. doi: 10.1080/07853890410018231.
7
Role of the HIF oxygen sensing pathway in cell defense and proliferation through the control of amino acid metabolism.HIF 氧感应途径通过控制氨基酸代谢在细胞防御和增殖中的作用。
Biochim Biophys Acta Mol Cell Res. 2020 Sep;1867(9):118733. doi: 10.1016/j.bbamcr.2020.118733. Epub 2020 May 13.
8
Hypoxia-Inducible Factor Regulates Endothelial Metabolism in Cardiovascular Disease.缺氧诱导因子在心血管疾病中调节内皮细胞代谢。
Front Physiol. 2021 Jul 5;12:670653. doi: 10.3389/fphys.2021.670653. eCollection 2021.
9
Perspective in chronic kidney disease: targeting hypoxia-inducible factor (HIF) as potential therapeutic approach.慢性肾脏病的研究进展:以缺氧诱导因子(HIF)为治疗靶点。
Ren Fail. 2012;34(4):521-32. doi: 10.3109/0886022X.2011.653754. Epub 2012 Jan 23.
10
JNK2 up-regulates hypoxia-inducible factors and contributes to hypoxia-induced erythropoiesis and pulmonary hypertension.JNK2 上调低氧诱导因子,促进低氧诱导的红细胞生成和肺动脉高压。
J Biol Chem. 2018 Jan 5;293(1):271-284. doi: 10.1074/jbc.RA117.000440. Epub 2017 Nov 8.

引用本文的文献

1
Metabolic Plasticity and Transcriptomic Reprogramming Orchestrate Hypoxia Adaptation in Yak.代谢可塑性和转录组重编程协同调控牦牛的低氧适应。
Animals (Basel). 2025 Jul 15;15(14):2084. doi: 10.3390/ani15142084.
2
Mesenchymal stem cell-derived exosomes improve vascular remodeling by inhibiting EGFR/ErbB2 heterodimerization in hypoxic pulmonary hypertension.间充质干细胞衍生的外泌体通过抑制缺氧性肺动脉高压中的EGFR/ErbB2异二聚体化来改善血管重塑。
Sci Rep. 2025 Jul 7;15(1):24303. doi: 10.1038/s41598-025-09333-z.
3
Molecular and Biochemical Mechanisms of Cardiomyopathy Development Following Prenatal Hypoxia-Focus on the NO System.

本文引用的文献

1
Hypoxia-inducible factor-1α in acute ischemic stroke: neuroprotection for better clinical outcome.急性缺血性卒中中的缺氧诱导因子-1α:神经保护作用以改善临床结局
Heliyon. 2020 Jun 28;6(6):e04286. doi: 10.1016/j.heliyon.2020.e04286. eCollection 2020 Jun.
2
Cardiac natriuretic peptides.心脏利钠肽。
Nat Rev Cardiol. 2020 Nov;17(11):698-717. doi: 10.1038/s41569-020-0381-0. Epub 2020 May 22.
3
Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis.
产前缺氧后心肌病发展的分子和生化机制——聚焦于一氧化氮系统
Antioxidants (Basel). 2025 Jun 16;14(6):743. doi: 10.3390/antiox14060743.
4
Loss of RET-ROS at complex I induces diastolic dysfunction in mice that is reversed by aerobic exercise.复合体I处RET-ROS的缺失会诱发小鼠舒张功能障碍,而有氧运动可使其逆转。
Am J Physiol Heart Circ Physiol. 2025 Jul 1;329(1):H154-H168. doi: 10.1152/ajpheart.00482.2024. Epub 2025 May 6.
5
Hypoxia-inducible factor and cellular senescence in pulmonary aging and disease.低氧诱导因子与肺衰老和疾病中的细胞衰老
Biogerontology. 2025 Feb 26;26(2):64. doi: 10.1007/s10522-025-10208-z.
6
Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions.针对脑缺血中线粒体功能障碍:药理学干预进展
Antioxidants (Basel). 2025 Jan 18;14(1):108. doi: 10.3390/antiox14010108.
7
Protective Effects of Anethole in Mill. Seed Ethanol Extract on Hypoxia/Reoxygenation Injury in H9C2 Heart Myoblast Cells.小茴香醚在小茴香籽乙醇提取物中对H9C2心肌成肌细胞缺氧/复氧损伤的保护作用
Antioxidants (Basel). 2024 Sep 25;13(10):1161. doi: 10.3390/antiox13101161.
8
Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndrome.唐氏综合征中失调的血红素代谢、缺氧信号和应激性红细胞生成的多模态分析。
Cell Rep. 2024 Aug 27;43(8):114599. doi: 10.1016/j.celrep.2024.114599. Epub 2024 Aug 8.
9
Hypoxia and re-oxygenation effects on human cardiomyocytes cultured on polycaprolactone and polyurethane nanofibrous mats.缺氧和复氧对在聚己内酯和聚氨酯纳米纤维垫上培养的人心肌细胞的影响。
J Biol Eng. 2024 Jun 6;18(1):37. doi: 10.1186/s13036-024-00432-5.
10
Effects of Hypoxia and Reoxygenation on Metabolic Profiles of Cardiomyocytes.缺氧及再复氧对心肌细胞代谢谱的影响。
Cell Biochem Biophys. 2024 Jun;82(2):969-985. doi: 10.1007/s12013-024-01249-1. Epub 2024 Mar 18.
2009 年至 2019 年期间欧洲、北美和澳大利亚脓毒症和脓毒性休克患者的死亡率:系统评价和荟萃分析的结果。
Crit Care. 2020 May 19;24(1):239. doi: 10.1186/s13054-020-02950-2.
4
Monitoring mitochondrial PO2: the next step.监测线粒体 PO2:下一步。
Curr Opin Crit Care. 2020 Jun;26(3):289-295. doi: 10.1097/MCC.0000000000000719.
5
Hypoxia-Inducible Factor 1α and 2α Have Beneficial Effects in Remote Ischemic Preconditioning Against Stroke by Modulating Inflammatory Responses in Aged Rats.缺氧诱导因子1α和2α通过调节老年大鼠的炎症反应,在远程缺血预处理预防中风中发挥有益作用。
Front Aging Neurosci. 2020 Mar 10;12:54. doi: 10.3389/fnagi.2020.00054. eCollection 2020.
6
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.《心脏病与卒中统计-2020 更新:来自美国心脏协会的报告》。
Circulation. 2020 Mar 3;141(9):e139-e596. doi: 10.1161/CIR.0000000000000757. Epub 2020 Jan 29.
7
Oral roxadustat three times weekly in ESA-naïve and ESA-converted patients with anemia of chronic kidney disease on hemodialysis: Results from two phase 3 studies.罗沙司他每周口服 3 次治疗血液透析慢性肾脏病贫血患者:两项 3 期研究结果。
Ther Apher Dial. 2020 Dec;24(6):628-641. doi: 10.1111/1744-9987.13468. Epub 2020 Feb 5.
8
Immunometabolism and Sepsis: A Role for HIF?免疫代谢与脓毒症:缺氧诱导因子起作用吗?
Front Mol Biosci. 2019 Sep 6;6:85. doi: 10.3389/fmolb.2019.00085. eCollection 2019.
9
Association of Age with the Expression of Hypoxia-Inducible Factors HIF-1α, HIF-2α, HIF-3α and VEGF in Lung and Heart of Tibetan Sheep.年龄与藏绵羊肺和心脏中缺氧诱导因子HIF-1α、HIF-2α、HIF-3α及血管内皮生长因子(VEGF)表达的相关性
Animals (Basel). 2019 Sep 11;9(9):673. doi: 10.3390/ani9090673.
10
Evaluation of Plasma Adenosine as a Marker of Cardiovascular Risk: Analytical and Biological Considerations.评估血浆腺苷作为心血管风险标志物:分析和生物学考虑。
J Am Heart Assoc. 2019 Aug 6;8(15):e012228. doi: 10.1161/JAHA.119.012228. Epub 2019 Aug 5.